Pharmaceutical & Biotech
News and Insights
High Price for Gilead’s Hepatitis C Treatment
Gilead's new hepatitis C treatment Savaldi came on the market in December. At that time, patients were receiving approval for the $84,000 treatment. Fast forward ...
Projected Top 10 Brands in 2020
With over $76 billion dollars in sales, 2013 was a good year for the best-selling drugs. According to EvaluatePharms'a annual world preview report, the top ...
AbbVie Continues its Quest for Shire
After three failed attempts, AbbVie has put together a $51.5 billion dollar deal to acquire Shire. AbbVie would like to expand on its top selling ...
Cubist Receives FDA Approval
Cubist has received FDA approval for Sivextro, an antibacterial drug it acquired after buying Trius about a year ago. This drug can be used to ...
Chicago to sue 5 Big Pharma Companies
Civil conspiracy and fraud are listed in a complaint that has been filed by the city of Chicago against five big pharma companies. This follows a ...
Possible Treatment for Type 2 Diabetes
Canadian researchers have found a naturally occurring molecule that could be used to treat individuals with insulin resistance and Type 2 diabetes. The molecule, called ...
FDA Steps in to Reduce Sleep Drug Dosages
In order to ensure that individuals are clear headed and not impaired by day after effects of taking a sleep aid, the FDA has required ...
Novartis Finishes First Quarter Strong
Prior to the end of the first quarter of 2014, Novartis announced that it had reached agreements with GlaxoSmithKline and Eli Lilly. Both agreements are ...
New Computer Bug Compromises Safety of Online Health Info
A new "Heartbleed" computer bug has wreaked havoc on the safety of online health records. This bug has compromised the OpenSSL program which thousands of ...
Eli Lilly to Invest in Drug Tracking System
In an effort to ensure patients are receiving non-counterfeit drugs, Eli Lilly will be investing $110 million into a new tracking system. This system will ...
- page 1 of 2 -